Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effectiveness of a high-throughput genetic analysis in the identification of responders/non-responders to CYP2D6-metabolized drugs.

Clinical laboratory - 1 Jan 2011

Savino Maria, Seripa Davide, Gallo Antonietta P, Garrubba Maria, D'Onofrio Grazia, Bizzarro Alessandra, Paroni Giulia, Paris Francesco, Mecocci Patrizia, Masullo Carlo, Pilotto Alberto, Santini Stefano A

Abstract excerpt

BACKGROUND: Recent studies investigating the single cytochrome P450 (CYP) 2D6 allele *2A reported an association with the response to drug treatments. More genetic data can be obtained, however, by high-throughput based-technologies. Aim of this study is the high-throughput analysis of the CYP2D6...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biotransformation
Share to Cytochrome P-450 CYP2D6

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance

Share to Gene Duplication

Share to Indans

Share to Piperidines

Share to Sampling Studies

Share to Single-Blind Method

Source

Identifiers

PMID: 22239018

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22239018-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effectiveness of a high-throughput genetic analysis in the identification of responders/non-responders to CYP2D6-metabolized drugs.PMID 22239018Read ↗

How and why to screen for CYP2D6 interindividual variability in patients under pharmacological treatments.Semantic proximity Read ↗

Development and characterization of a rapid and comprehensive genotyping assay to detect the most common variants in cytochrome P450 2D6.Semantic proximity Read ↗

A new simple diagnostic assay for the identification of the major CYP2D6 genotypes by DNA sequencing analysis.Semantic proximity Read ↗

Biomarkers in the era of personalized medicine - a multiplexed SNP assay using capillary electrophoresis for assessing drug metabolism capacity.Semantic proximity Read ↗

Cypiripi: exact genotyping of CYP2D6 using high-throughput sequencing data.Semantic proximity Read ↗

Rapid detection of the C-1496G polymorphism in the CYP2D6 *2 allele.Semantic proximity Read ↗

The CYP4502D6 *4 and *6 alleles are the molecular genetic markers for drug response: implications in colchicine non-responder FMF patients.Semantic proximity Read ↗

CYP2D6 genotype: impact on adverse effects and nonresponse during treatment with antidepressants-a pilot study.Semantic proximity Read ↗

Identification of CYP2D6 alleles by single nucleotide polymorphism analysis using pyrosequencing.Semantic proximity Read ↗

Developing and Evaluating the HRM Technique for Identifying Cytochrome P450 2D6 Polymorphisms.Semantic proximity Read ↗

CYP2A6 genotyping methods and strategies using real-time and end point PCR platforms.Semantic proximity Read ↗

Allele Drop Out Conferred by a Frequent CYP2D6 Genetic Variation For Commonly Used CYP2D6*3 Genotyping Assays.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.